Sun H - Search Results

1

Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma.

Liu J, Geng W, Sun H, Liu C, Huang F, Cao J, Xia L, Zhao H, Zhai J, Li Q, Zhang X, Kuang M, Shen S, Xia Q, Wong VW, Yu J. Liu J, et al. Among authors: sun h. Gut. 2022 Jun;71(6):1203-1213. doi: 10.1136/gutjnl-2021-325189. Epub 2021 Aug 3. Gut. 2022. PMID: 34344785 Free PMC article.

2

Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma.

Tian Y, Wong VW, Wong GL, Yang W, Sun H, Shen J, Tong JH, Go MY, Cheung YS, Lai PB, Zhou M, Xu G, Huang TH, Yu J, To KF, Cheng AS, Chan HL. Tian Y, et al. Among authors: sun h. Cancer Res. 2015 Nov 15;75(22):4803-16. doi: 10.1158/0008-5472.CAN-14-3786. Epub 2015 Sep 17. Cancer Res. 2015. PMID: 26383163

3

Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.

Zhou J, Liu M, Sun H, Feng Y, Xu L, Chan AWH, Tong JH, Wong J, Chong CCN, Lai PBS, Wang HK, Tsang SW, Goodwin T, Liu R, Huang L, Chen Z, Sung JJ, Chow KL, To KF, Cheng AS. Zhou J, et al. Among authors: sun h. Gut. 2018 May;67(5):931-944. doi: 10.1136/gutjnl-2017-314032. Epub 2017 Sep 22. Gut. 2018. PMID: 28939663 Free PMC article.

4

Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis.

Sha M, Jeong S, Chen XS, Tong Y, Cao J, Sun HY, Xia L, Xu N, Wang X, Han LZ, Xi ZF, Zhang JJ, Kong XN, Xia Q. Sha M, et al. Int J Biol Sci. 2018 Jul 27;14(10):1333-1342. doi: 10.7150/ijbs.26045. eCollection 2018. Int J Biol Sci. 2018. PMID: 30123080 Free PMC article.

5

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma.

Sha M, Jeong S, Wang X, Tong Y, Cao J, Sun HY, Xia L, Xu N, Xi ZF, Zhang JJ, Kong XN, Xia Q. Sha M, et al. BMC Cancer. 2019 Mar 8;19(1):208. doi: 10.1186/s12885-019-5420-z. BMC Cancer. 2019. PMID: 30849953 Free PMC article.

6

Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.

Liu M, Zhou J, Liu X, Feng Y, Yang W, Wu F, Cheung OK, Sun H, Zeng X, Tang W, Mok MTS, Wong J, Yeung PC, Lai PBS, Chen Z, Jin H, Chen J, Chan SL, Chan AWH, To KF, Sung JJY, Chen M, Cheng AS. Liu M, et al. Among authors: sun h. Gut. 2020 Feb;69(2):365-379. doi: 10.1136/gutjnl-2018-317257. Epub 2019 May 10. Gut. 2020. PMID: 31076403

7

Neuroendocrine regulation of cholangiocarcinoma: A status quo review.

Sha M, Cao J, Sun HY, Tong Y, Xia Q. Sha M, et al. Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):66-73. doi: 10.1016/j.bbcan.2019.05.005. Epub 2019 May 30. Biochim Biophys Acta Rev Cancer. 2019. PMID: 31152820 Review.

8

Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis.

Zeng X, Zhou J, Xiong Z, Sun H, Yang W, Mok MTS, Wang J, Li J, Liu M, Tang W, Feng Y, Wang HK, Tsang SW, Chow KL, Yeung PC, Wong J, Lai PB, Chan AW, To KF, Chan SL, Xia Q, Xue J, Chen X, Yu J, Peng S, Sung JJ, Kuang M, Cheng AS. Zeng X, et al. Among authors: sun h. Cell Mol Immunol. 2021 Apr;18(4):1005-1015. doi: 10.1038/s41423-020-00534-2. Epub 2020 Sep 2. Cell Mol Immunol. 2021. PMID: 32879468 Free PMC article.

9

Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The TEA cohort to evaluate long-term post-Transplant outcomes.

Xia L, Qiao ZY, Zhang ZJ, Lv ZC, Tong H, Tong Y, Wu HX, Chen XS, Sun HY, Zhang JJ, Thasler WE, Feng H, Xia Q. Xia L, et al. Among authors: sun hy. EClinicalMedicine. 2022 Jun 4;49:101476. doi: 10.1016/j.eclinm.2022.101476. eCollection 2022 Jul. EClinicalMedicine. 2022. PMID: 35747194 Free PMC article.

10

Clinical analysis of deceased donor liver transplantation in the treatment of hepatocellular carcinoma with segmental portal vein tumor thrombus: A long-term real-world study.

Sha M, Chen C, Shen C, Jeong S, Sun HY, Xu N, Hang HL, Cao J, Tong Y. Sha M, et al. Front Oncol. 2022 Sep 20;12:971532. doi: 10.3389/fonc.2022.971532. eCollection 2022. Front Oncol. 2022. PMID: 36203429 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29,803 results

Search Page